196 related articles for article (PubMed ID: 2894215)
1. Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonist.
Cameron HA; Waller PC; Ramsay LE
Br J Clin Pharmacol; 1987 Dec; 24(6):705-11. PubMed ID: 2894215
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ketanserin and slow-release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta-adrenoceptor blocker.
Waller PC; Solomon SA; Ramsay LE
Br J Clin Pharmacol; 1987 Nov; 24(5):591-7. PubMed ID: 2893636
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive efficacy of ketanserin alone or in combination with a beta-blocker or a diuretic: the Swiss Ketanserin Study.
Beretta-Piccoli C; Amstein R; Bertel O; Brunner HR; Bühler FR; Follath F; Solèr M; Vallotton M
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S119-23. PubMed ID: 2446058
[TBL] [Abstract][Full Text] [Related]
4. Effect of ketanserin on blood pressure and biochemical parameters in patients with essential hypertension.
Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S164-7. PubMed ID: 2412043
[TBL] [Abstract][Full Text] [Related]
5. The effect of ketanserin on blood pressure and biochemical parameters in treated patients with essential hypertension.
Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
Clin Exp Hypertens A; 1984; 6(6):1107-17. PubMed ID: 6146414
[TBL] [Abstract][Full Text] [Related]
6. Ketanserin combined with a beta-blocker or diuretic in essential hypertension. A multicentre study.
Bartoloni C; Dupont P; Feltkamp H; Johnston CI; Steinbach K; Zilcher H; Kaindl F
Eur J Clin Pharmacol; 1988; 35(6):573-7. PubMed ID: 2906874
[TBL] [Abstract][Full Text] [Related]
7. Serotonin antagonism reduces the adverse symptoms of beta blockade.
Korlipara K; Gould SE; Taylor NA; Chandler A
Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():127-31. PubMed ID: 1981022
[TBL] [Abstract][Full Text] [Related]
8. Serotonergic blockade compared with beta-adrenergic blockade in systemic hypertension: a double-blind comparison of ketanserin with propranolol.
Okin S; Huberfeld SI; Frishman WH; Soberman J; Laifer L; Greenberg S; Lapsker J; Charlap S; Strom JA
J Clin Pharmacol; 1988 Nov; 28(11):1008-16. PubMed ID: 2907519
[TBL] [Abstract][Full Text] [Related]
9. Ketanserin in the treatment of essential hypertension. A double-blind study against metoprolol and a further long-term open treatment.
Milei J; Lemus J; Bernardiner E
Acta Cardiol; 1986; 41(6):427-41. PubMed ID: 3544622
[TBL] [Abstract][Full Text] [Related]
10. [Blood pressure lowering action and tolerance of ketanserin in mono- or combination therapy].
Beretta-Piccoli C; Amstein R; Bühler FR; Bertel O; Brunner HR; Follath F; Reutter F; Vallotton MB
Schweiz Med Wochenschr; 1989 Mar; 119(12):399-406. PubMed ID: 2711155
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive efficacy and well-being during monotherapy and combination therapy with ketanserin.
Amstein R; Bühler FR; Beretta-Piccoli C; Bertel O; Brunner HR; Follath F; Heer K; Reutter F; Vallotton MB
J Hypertens; 1989 Aug; 7(8):619-24. PubMed ID: 2809191
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive therapy with ketanserin: metabolic and hemodynamic effects.
Levinson PD; Zimlichman R; Goldstein DS; Keiser HR
J Cardiovasc Pharmacol; 1988 Oct; 12(4):384-9. PubMed ID: 2465437
[TBL] [Abstract][Full Text] [Related]
13. Felodipine in hypertensive patients. A dose finding study in patients refractory to beta-blocker monotherapy.
Sluiter HE
Drugs; 1987; 34 Suppl 3():97-106. PubMed ID: 2894980
[TBL] [Abstract][Full Text] [Related]
14. [A cross-over study of ketanserin compared to placebo, beta-adrenergic blockader, diuretic and alpha 1-adrenergic blockader. Cooperative research in the USSR (the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension). Working Group (4)].
Metelitsa VI; Filatova NP
Ter Arkh; 1991; 63(9):91-6. PubMed ID: 1684678
[TBL] [Abstract][Full Text] [Related]
15. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
[TBL] [Abstract][Full Text] [Related]
16. Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension.
Hedner T; Persson B
Br J Clin Pharmacol; 1984 Nov; 18(5):765-71. PubMed ID: 6150724
[TBL] [Abstract][Full Text] [Related]
17. A double-blind comparative study of ketanserin with atenolol in essential hypertension.
Antonicelli R; Andreoni A; Saccomanno G; Gambini C; Paciaroni E
Drugs Exp Clin Res; 1989; 15(11-12):577-81. PubMed ID: 2700320
[TBL] [Abstract][Full Text] [Related]
18. Long term experience of felodipine in combination with beta-blockade and diuretics in refractory hypertension.
Collste P; Danielsson M; Elmfeldt D; Feleke E; Gelin A; Hedner T; Rydén L
Drugs; 1985; 29 Suppl 2():124-30. PubMed ID: 2859184
[TBL] [Abstract][Full Text] [Related]
19. Experience with terazosin administered in combination with other antihypertensive agents.
Chrysant SG
Am J Med; 1986 May; 80(5B):55-61. PubMed ID: 2872808
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive efficacy of the calcium-antagonist felodipine in patients with persisting hypertension on beta-adrenoceptor blocker therapy. The Canadian Felodipine Study Group.
Br J Clin Pharmacol; 1988 Nov; 26(5):535-45. PubMed ID: 2905154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
